3 Stocks Underperforming Today In The Health Services Industry

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 22 points (0.1%) at 16,756 as of Friday, June 13, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,558 issues advancing vs. 1,369 declining with 183 unchanged.

The Health Services industry currently sits down 0.3% versus the S&P 500, which is up 0.2%. On the negative front, top decliners within the industry include WuXi PharmaTech (Cayman ( WX), down 4.6%, Bruker ( BRKR), down 1.9%, Grifols ( GRFS), down 1.1%, CR Bard ( BCR), down 1.0% and Smith & Nephew ( SNN), down 0.9%. A company within the industry that increased today was Waters ( WAT), up 0.6%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. Tenet Healthcare ( THC) is one of the companies pushing the Health Services industry lower today. As of noon trading, Tenet Healthcare is down $0.85 (-1.8%) to $46.92 on light volume. Thus far, 623,437 shares of Tenet Healthcare exchanged hands as compared to its average daily volume of 1.7 million shares. The stock has ranged in price between $46.83-$47.86 after having opened the day at $47.72 as compared to the previous trading day's close of $47.77.

Tenet Healthcare Corporation, an investor-owned health care services company, primarily operates acute care hospitals and related health care facilities in the United States. Tenet Healthcare has a market cap of $4.7 billion and is part of the health care sector. Shares are up 13.4% year-to-date as of the close of trading on Thursday. Currently there are 7 analysts that rate Tenet Healthcare a buy, 1 analyst rates it a sell, and 7 rate it a hold.

TheStreet Ratings rates Tenet Healthcare as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and increase in net income. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk, disappointing return on equity and poor profit margins. Get the full Tenet Healthcare Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

Friday Selloff May Be On Its Way; Tenet Gears Up for Sale -- ICYMI

Dow Posts Fresh Record, Third in a Row, but S&P 500 and Nasdaq Fall

Boeing, United Tech Lead Dow to Records but Rest of Market Flounders

No Buyers for All of Tenet, Analysts Say

Jim Cramer on Amazon, Walmart, Equifax, Tesla and Tenet Healthcare